A TENACIOUS PURSUIT FOR LIFE
A commitment to
transform the treatment
of neurological diseases
Pipeline
We are advancing a deep and diverse pipeline of wholly owned, highly CNS–penetrant as well as peripherally–restricted small molecules that address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function
News
Keep up to date with the world of Tenvie
About Us
Ten\vie: the tenacious (Ten\) pursuit to improve the lives (\vie) of patients and caregivers.
Tenvie was purpose-built with a deep and diverse portfolio and a proven team of CNS drug developers with a collective track record of engineering and developing small molecule therapies.
Contact
Reach out to us